PT Kalbe Farma Tbk Total Revenue

As of the most recent data (June 2026), PTKFF shows a total revenue of $29T. That compares with $25T in the prior-year period — up 13.5% year over year. That is above the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTKFF's total revenue is now $29T (was $25T) — a 13.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PT Kalbe Farma Tbk is outperforming or lagging.

The Healthcare sector average total revenue is about $110B. PT Kalbe Farma Tbk is at $29T, which is higher that average. That is roughly 25460.4% above the sector mean. Use the comparison chart on this page to see how PTKFF stacks up against individual peers as well.

Tracking PTKFF's total revenue over time shows whether PT Kalbe Farma Tbk is scaling, shrinking, or reshaping that part of the business. The current reading is $29T That compares with $25T in the prior-year period — up 13.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has PT Kalbe Farma Tbk's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $29T) with ownership activity and broader fundamentals.